Ku86 is important for TrkA overexpression-induced breast cancer cell invasion

Proteomics - Clinical Applications

Volumn 4, Issue 6-7, 2010, Pages 580-590

  Lagadec, Chann ^a   Romon, Rodrigue ^a   Tastet, Christophe ^a   Meignan, Samuel ^a   Com, Emmanuelle ^a   Page, Adeline ^a   Bidaux, Gabriel ^b   Hondermarck, Hubert ^a   Le Bourhis, Xuefen ^a  

^a UNIV LILLE   (France)

^b Université des Sciences et Technologies de Lille   (France)

Author keywords

Breast cancer; Cell invasio; Ku proteins; TrkA tyrosine kinase receptor

Indexed keywords

KU ANTIGEN; NEUTRALIZING ANTIBODY; PROTEIN KU86; PROTEIN TYROSINE KINASE A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; GENE IDENTIFICATION; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

ANIMALIA;

EID: 77955776873     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900148     Document Type: Article

References (46)

1. Chan, S. K., Hill, M. E., Gullick, W. J., The role of the epidermal growth factor receptor in breast cancer. J. Mammary Gland. Biol. Neoplasia 2006, 11, 3-11.
2. Chang, C. F., Westbrook, R., Ma, J., Cao, D., Transforming growth factor-beta signaling in breast cancer. Front Biosci. 2007, 12, 4393-4401.
3. Mercurio, A. M., Lipscomb, E. A., Bachelder, R. E., Nonangiogenic functions of VEGF in breast cancer. J. Mammary Gland. Biol. Neoplasia 2005, 10, 283-290.
4. Roussidis, A. E., Theocharis, A. D., Tzanakakis, G. N., Karamanos, N. K., The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer. Curr. Med. Chem. 2007, 14, 735-743.
5. Papatsoris, A. G., Liolitsa, D., Deliveliotis, C., Manipulation of the nerve growth factor network in prostate cancer. Expert Opin. Investig. Drugs 2007,16, 303-309.
6. Nakagawara, A., Trk receptofr tyrosine kinases: a bridge between cancer and neural development. Cancer Lett. 2001, 169, 107-114.
7. Dolle, L., Adriaenssens, E., El Yazidi-Belkoura, I., Le Bourhis, X. et al., Nerve growth factor receptors and signaling in breast cancer. Curr. Cancer Drug Targets 2004, 4, 463-470.
8. Schramm, A., Schulte, J. H., Astrahantseff, K., Apostolov, O. et al., Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett. 2005, 228, 143-153.
9. Descamps, S., Lebourhis, X., Delehedde, M., Boilly, B., Hondermarck, H., Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J. Biol. Chem. 1998, 273, 16659-16662.
10. Descamps, S., Toillon, R. A., Adriaenssens, E., Pawlowski, V. et al., Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J. Biol. Chem. 2001, 276, 17864-17870.
11. Ohta, T., Watanabe, T., Katayama, Y., Kurihara, J. et al., TrkA expression is associated with an elevated level of apoptosis in classic medulloblastomas. Neuropathology 2006, 26, 170-177.
12. Adriaenssens, E., Vanhecke, E., Saule, P., Mougel, A. et al., Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 2008, 68, 346-351.
13. Lagadec, C.,Meignan, S., Adriaenssens, E., Foveau, B. et al., TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene 2009, 28, 1960-1970.
14. McGregor, L. M., McCune, B. K., Graff, J. R., McDowell, P. R. et al., Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. Proc. Natl. Acad Sci. USA 1999, 96, 4540-4545.
15. Ricci, A., Greco, S., Mariotta, S., Felici, L. et al., Neurotrophins and neurotrophin receptors in human lung cancer. Am. J. Respir. Cell Mol. Biol. 2001, 25, 439-446.
16. Friess, H., Zhu, Z. W., di Mola, F. F., Kulli, C. et al., Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann. Surg. 1999, 230, 615-624.
17. Zhu, Z., Friess, H., diMola, F. F., Zimmermann, A. et al., Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. J. Clin. Oncol. 1999, 17, 2419-2428.
18. Weeraratna, A. T., Arnold, J. T., George, D. J., DeMarzo, A., Isaacs, J. T., Rational basis for Trk inhibition therapy for prostate cancer. Prostate 2000, 45, 140-148.
19. Miknyoczki, S. J., Wan, W., Chang, H., Dobrzanski, P. et al., The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice. Clin. Cancer Res. 2002, 8, 1924-1931.
20. Campos, X., Munoz, Y., Selman, A., Yazigi, R. et al., Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. Gynecol. Oncol. 2007, 104, 168-175.
21. Davidson, B., Reich, R., Lazarovici, P., Nesland, J. M. et al., Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin. Cancer Res. 2003, 9, 2248-2259.
22. Chevallet, M., Tastet, C., Luche, S., Rabilloud, T., Preparing protein extracts for quantitative two-dimensional gel comparison. Curr. Protoc. Protein Sci. 2004, Chapter 22, Unit 22 24.
23. Gorg, A., Postel, W., Gunther, S., Weser, J. et al., Approach to stationary two-dimensional pattern: influence of focusing time and immobiline/carrier ampholytes concentrations. Electrophoresis 1988, 9, 37-46.
24. Tastet, C., Lescuyer, P., Diemer, H., Luche, S. et al., A versatile electrophoresis system for the analysis of highand low-molecular-weight proteins. Electrophoresis 2003, 24, 1787-1794.
25. Sinha, P., Poland, J., Schnolzer, M., Rabilloud, T., A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionization-time of flight analysis of proteins after two-dimensional electrophoresis. Proteomics 2001, 1, 835-840.
26. Neuhoff, V., Arold, N., Taube, D., Ehrhardt, W., Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988, 9, 255-262.
27. Com, E., Lagadec, C., Page, A., El Yazidi-Belkoura, I. et al., Nerve growth factor receptor TrkA signaling in breast cancer cells involves KU70 to prevent apoptosis. Mol. Cell Proteomics 2007, 6, 1842-1854.
28. Collis, S. J., DeWeese, T. L., Jeggo, P. A., Parker, A. R., The life and death of DNA-PK. Oncogene 2005, 24, 949-961.
29. Muller, C., Paupert, J., Monferran, S., Salles, B., The double life of the Ku protein: facing the DNA breaks and the extracellular environment. Cell Cycle 2005, 4, 438-441.
30. Lamberti, C., Pessione, E., Giuffrida, M. G., Mazzoli, R. et al., Combined cup loading, bis(2-hydroxyethyl) disulfide, and protein precipitation protocols to improve the alkaline proteome of Lactobacillus hilgardii. Electrophoresis 2007, 28, 1633-1638.
31. Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B. et al., Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol. Cell 2004, 13, 627-638.
32. Morio, T., Kim, H., Ku, Artemis, and ataxia-telangiectasiamutated: signalling networks in DNA damage. Int. J. Biochem. Cell Biol. 2008, 40, 598-603.
33. Gama, V., Gomez, J. A., Mayo, L. D., Jackson, M. W. et al., Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization. Cell Death Differ 2009, 16, 758-769.
34. Yaneva, M., Jhiang, S., Expression of the Ku protein during cell proliferation. Biochim. Biophys. Acta. 1991, 1090, 181-187.
35. Cai, Q. Q., Plet, A., Imbert, J., Lafage-Pochitaloff, M. et al., Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. Cytogenet Cell Genet 1994, 65, 221-227.
36. Klein, A., Miera, O., Bauer, O., Golfier, S., Schriever, F., Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair. Leukemia 2000, 14, 40-46.
37. Pucci, S., Mazzarelli, P., Rabitti, C., Giai, M. et al., Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene 2001, 20, 739-747.
38. Luk, J. M., Su, Y. C., Lam, S. C., Lee, C. K. et al., Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma. Proteomics 2005, 5, 1980-1986.
39. Seimiya, M., Tomonaga, T., Matsushita, K., Sunaga, M. et al., Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase. Hepatology 2008, 48, 519-530.
40. Mahaney, B. L., Meek, K., Lees-Miller, S. P., Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem. J. 2009, 417, 639-650.
41. Sawada, M., Hayes, P., Matsuyama, S., Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nat. Cell Biol. 2003, 5, 352-357.
42. Lynch, E. M., Moreland, R. B., Ginis, I., Perrine, S. P., Faller, D. V., Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am. J. Physiol. Cell Physiol. 2001, 280, C897-C911.
43. Tai, Y. T., Podar, K., Kraeft, S. K., Wang, F. et al., Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications. Exp. Hematol. 2002, 30, 212-220.
44. Ginis, I., Faller, D. V., Hypoxia affects tumor cell invasiveness in vitro: the role of hypoxia-activated ligand HAL1/13 (Ku86 autoantigen). Cancer Lett. 2000, 154, 163-174.
45. Monferran, S., Paupert, J., Dauvillier, S., Salles, B., Muller, C., The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. Embo. J. 2004, 23, 3758-3768.
46. Paupert, J., Dauvillier, S., Salles, B., Muller, C., Transport of the leaderless protein Ku on the cell surface of activated monocytes regulates their migratory abilities. EMBO Rep. 2007, 8, 583-588.